{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:15:36Z","timestamp":1793898936082,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The estimated glucose disposal rate (eGDR), calculated from glycated hemoglobin (HbA1c), hypertension status and BMI, is a proxy for insulin resistance. We examined the association between eGDR and the risk of first myocardial infarction (MI) and post-MI mortality in individuals with type 1 and type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using nationwide health registry data (2006\u20132020), we identified individuals with type 1 and type 2 diabetes. Follow-up started at the first time a complete eGDR could be calculated. eGDR was then handled as a time-updated exposure until first MI, with person-time assigned according to the most recent available value. Among those with MI, follow-up for post-MI mortality started at the event, and covariates were fixed at their last value before MI. Hazard ratios (HRs) with 95% CIs were estimated using Cox regression with adjustment for blood lipids, albuminuria, estimated glomerular filtration rate and physical activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 46,155 individuals with type 1 diabetes and 570,230 individuals with type 2 diabetes (both 43% women). During a median follow up of 7.7 person-years, 1997 (4.3%) and 34,237 (6.0%) experienced first MI, respectively. Adjusted HRs (95% CIs) for first MI across eGDR categories \u22644, 4\u20136, 6\u20138, and \u22658\u00a0mg\/kg\/min) were: 3.73 (3.35\u20134.16), 3.09 (2.85\u20133.35), 2.40 (2.15\u20132.69) and 0.96 (0.79\u20131.17) for type 1 diabetes, respectively. Corresponding HRs for type 2 diabetes were 1.71 (1.62\u20131.82), 1.54 (1.46\u20131.62), 1.43 (1.35\u20131.51) and 1 (reference). Similar associations were observed for post-MI mortality, however non-significant across all eGDR categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lower eGDR, reflecting greater insulin resistance, was associated with a higher risk of first MI, with a stronger association observed in type 1 diabetes. These findings support insulin resistance as a potential modifiable cardiovascular risk factor in people with diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40842-026-00294-4","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T22:06:56Z","timestamp":1779660416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Estimated glucose disposal rate and risk of first myocardial infarction in people with diabetes"],"prefix":"10.1186","volume":"12","author":[{"given":"Linn","family":"Glynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"25","key":"294_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"294_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrendo.2012.47","volume":"8","author":"SJ Cleland","year":"2012","unstructured":"Cleland SJ. Cardiovascular risk in double diabetes mellitus\u2013when two worlds collide. Nat Rev Endocrinol. 2012;8(8):476\u201385.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"294_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41366-023-01429-8","volume":"48","author":"MTW Kueh","year":"2024","unstructured":"Kueh MTW, Chew NWS, Al-Ozairi E, le Roux CW. The emergence of obesity in type 1 diabetes. Int J Obes (Lond). 2024;48(3):289\u2013301.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"294_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"294_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/dom.13110","volume":"20","author":"T Nystr\u00f6m","year":"2018","unstructured":"Nystr\u00f6m T, Holzmann MJ, Eliasson B, Svensson AM, Sartipy U. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metab. 2018;20(3):556\u201363.","journal-title":"Diabetes Obes Metab"},{"issue":"9733","key":"294_CR6","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215\u201322.","journal-title":"Lancet"},{"issue":"1","key":"294_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12933-022-01498-5","volume":"21","author":"M Saeed","year":"2022","unstructured":"Saeed M, Stene LC, Ariansen I, Tell GS, Tapia G, Joner G, Skrivarhaug T. Nine-fold higher risk of acute myocardial infarction in subjects with type 1 diabetes compared to controls in Norway 1973\u20132017. Cardiovasc Diabetol. 2022;21(1):59.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"294_CR8","doi-asserted-by":"publisher","first-page":"e034741","DOI":"10.1161\/JAHA.123.034741","volume":"13","author":"L Glynn","year":"2024","unstructured":"Glynn L, Lind M, Andersson T, Eliasson B, Hofmann R, Nystr\u00f6m T. Trends in Survival After First Myocardial Infarction in People With Diabetes. J Am Heart Assoc. 2024;13(10):e034741.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"294_CR9","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214\u2013223.","journal-title":"Am J Physiol"},{"issue":"4","key":"294_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","volume":"49","author":"KV Williams","year":"2000","unstructured":"Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626\u201332.","journal-title":"Diabetes"},{"issue":"1","key":"294_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-021-01394-4","volume":"20","author":"A Zabala","year":"2021","unstructured":"Zabala A, Darsalia V, Lind M, Svensson AM, Franz\u00e9n S, Eliasson B, Patrone C, Jonsson M, Nystr\u00f6m T. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2021;20(1):202.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"294_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12933-023-01791-x","volume":"22","author":"W Linn","year":"2023","unstructured":"Linn W, Persson M, Rathsman B, Ludvigsson J, Lind M, Andersson Franko M, Nystr\u00f6m T. Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study. Cardiovasc Diabetol. 2023;22(1):61.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"294_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2337\/diacare.26.5.1374","volume":"26","author":"TJ Orchard","year":"2003","unstructured":"Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, Ellis D, Becker DJ. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2003;26(5):1374\u20139.","journal-title":"Diabetes Care"},{"issue":"1","key":"294_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12916-025-04064-4","volume":"23","author":"L Guo","year":"2025","unstructured":"Guo L, Zhang J, An R, Wang W, Fen J, Wu Y, Wang Y. The role of estimated glucose disposal rate in predicting cardiovascular risk among general and diabetes mellitus population: a systematic review and meta-analysis. BMC Med. 2025;23(1):234.","journal-title":"BMC Med"},{"issue":"3","key":"294_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00380-016-0875-1","volume":"32","author":"T Nystr\u00f6m","year":"2017","unstructured":"Nystr\u00f6m T, Holzmann MJ, Eliasson B, Svensson AM, Kuhl J, Sartipy U. Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting. Heart Vessels. 2017;32(3):269\u201378.","journal-title":"Heart Vessels"},{"issue":"7","key":"294_CR16","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2337\/dc10-0398","volume":"33","author":"K Eeg-Olofsson","year":"2010","unstructured":"Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson AM, Gudbj\u00f6rnsd\u00f3ttir S, Eliasson B. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care. 2010;33(7):1640\u20136.","journal-title":"Diabetes Care"},{"key":"294_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"issue":"9","key":"294_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke HL, Talb\u00e4ck M, H\u00f6rnblad J, Johansson LA, Ludvigsson JF, Druid H, Feychting M, Ljung R. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765\u201373.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"294_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bcpt.12613","volume":"119","author":"SM Wallerstedt","year":"2016","unstructured":"Wallerstedt SM, Wettermark B, Hoffmann M. The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific Literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"294_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Svedberg P, Ol\u00e9n O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423\u201337.","journal-title":"Eur J Epidemiol"},{"issue":"Supplement1","key":"294_CR21","first-page":"S27","volume":"49","author":"2","year":"2026","unstructured":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Supplement1):S27\u201349.","journal-title":"Diabetes Care"},{"key":"294_CR22","unstructured":"Diabetesregistret N. \u00c5rsrapport Nationella Diabetesregistret 2024. In. Gothenburg; 2024."},{"issue":"1","key":"294_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1373\/clinchem.2003.024802","volume":"50","author":"W Hoelzel","year":"2004","unstructured":"Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004;50(1):166\u201374.","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"294_CR24","first-page":"S179","volume":"47","author":"10","year":"2024","unstructured":"10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S179\u2013218.","journal-title":"Diabetes Care"},{"issue":"11","key":"294_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","volume":"138","author":"G Maldonado","year":"1993","unstructured":"Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923\u201336.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"294_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-023-02093-y","volume":"23","author":"A Riccio","year":"2024","unstructured":"Riccio A, Fortin E, Mellbin L, Norhammar A, N\u00e4sman P, Ryd\u00e9n L, Sesti G, Ferrannini G. Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states. Cardiovasc Diabetol. 2024;23(1):25.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"294_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-025-02712-w","volume":"24","author":"R Oh","year":"2025","unstructured":"Oh R, Kim S, Park SH, Jang M, Cho SH, Kim JY, Lee YB, Jin SM, Hur KY, Kim G, et al. Elevated triglyceride-glucose index is a risk factor for cardiovascular events in adults with type 1 diabetes: a cohort study. Cardiovasc Diabetol. 2025;24(1):150.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"294_CR28","doi-asserted-by":"publisher","first-page":"103686","DOI":"10.1016\/j.numecd.2024.07.004","volume":"35","author":"MJ Kim","year":"2025","unstructured":"Kim MJ, Cho YK, Kim EH, Lee MJ, Lee WJ, Kim HK, Jung CH. Association between estimated glucose disposal rate and subclinical coronary atherosclerosis. Nutr Metab Cardiovasc Dis. 2025;35(1):103686.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"294_CR29","doi-asserted-by":"publisher","first-page":"e3323","DOI":"10.1002\/dmrr.3323","volume":"36","author":"A Pan\u00e9","year":"2020","unstructured":"Pan\u00e9 A, Conget I, Boswell L, Ruiz S, Vi\u00f1als C, Perea V, Gim\u00e9nez M, Cof\u00e1n M, Blanco J, Vinagre I, et al. Insulin resistance is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. Diabetes Metab Res Rev. 2020;36(7):e3323.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"294_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/db10-0328","volume":"60","author":"IE Schauer","year":"2011","unstructured":"Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, Rewers M. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes. 2011;60(1):306\u201314.","journal-title":"Diabetes"},{"key":"294_CR31","doi-asserted-by":"crossref","unstructured":"Sun R, Wang J, Li M, Li J, Pan Y, Liu B, Lip GYH, Zhang L. Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analysis. Diabetes Care. 2024.","DOI":"10.2337\/figshare.26083753"},{"issue":"2","key":"294_CR32","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1210\/jc.2015-3272","volume":"101","author":"LM Duca","year":"2016","unstructured":"Duca LM, Maahs DM, Schauer IE, Bergman BC, Nadeau KJ, Bjornstad P, Rewers M, Snell-Bergeon JK. Development and Validation of a Method to Estimate Insulin Sensitivity in Patients With and Without Type 1 Diabetes. J Clin Endocrinol Metab. 2016;101(2):686\u201395.","journal-title":"J Clin Endocrinol Metab"},{"key":"294_CR33","doi-asserted-by":"publisher","first-page":"108359","DOI":"10.1016\/j.diabres.2020.108359","volume":"167","author":"AS Januszewski","year":"2020","unstructured":"Januszewski AS, Sachithanandan N, Ward G, Karschimkus CS, O\u2019Neal DN, Jenkins AJ. Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers. Diabetes Res Clin Pract. 2020;167:108359.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"294_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000471488","volume":"10","author":"GH Goossens","year":"2017","unstructured":"Goossens GH. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017;10(3):207\u201315.","journal-title":"Obes Facts"},{"issue":"10","key":"294_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301\u201313.","journal-title":"Circulation"},{"issue":"1","key":"294_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-024-02570-y","volume":"24","author":"J Liao","year":"2025","unstructured":"Liao J, Wang L, Duan L, Gong F, Zhu H, Pan H, Yang H. Association between estimated glucose disposal rate and cardiovascular diseases in patients with diabetes or prediabetes: a cross-sectional study. Cardiovasc Diabetol. 2025;24(1):13.","journal-title":"Cardiovasc Diabetol"},{"issue":"24","key":"294_CR37","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016;133(24):2459\u2013502.","journal-title":"Circulation"},{"key":"294_CR38","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/j.diabres.2022.109899","volume":"188","author":"M de Jong","year":"2022","unstructured":"de Jong M, Woodward M, Peters SAE. Duration of diabetes and the risk of major cardiovascular events in women and men: A prospective cohort study of UK Biobank participants. Diabetes Res Clin Pract. 2022;188:109899.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"294_CR39","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","volume":"57","author":"S Zoungas","year":"2014","unstructured":"Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, Marre M, Patel A, Poulter N, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465\u201374.","journal-title":"Diabetologia"},{"key":"294_CR40","doi-asserted-by":"crossref","unstructured":"Carlsson S, Andersson T, Jansson S, Nystr\u00f6m T, Rolandsson O, Wei Y. Increasing incidence of early-onset type 2 diabetes in Sweden 2006\u20132021. Eur J Public Health. 2025.","DOI":"10.1093\/eurpub\/ckaf114"},{"issue":"31","key":"294_CR41","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","volume":"34","author":"F Paneni","year":"2013","unstructured":"Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436\u201343.","journal-title":"Eur Heart J"},{"issue":"15","key":"294_CR42","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Franz\u00e9n S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbj\u00f6rnsdottir S. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med. 2017;376(15):1407\u201318.","journal-title":"N Engl J Med"},{"issue":"10","key":"294_CR43","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.1111\/dom.16606","volume":"27","author":"EB Stougaard","year":"2025","unstructured":"Stougaard EB, Andersen MR, Bagger JI, S\u00f8ndergaard E, \u00d8stergaard JA, Curovic VR, Persson F, Almdal T, Mathiesen AS, Andries A, et al. The Steno 1 study: Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes-rationale and protocol of the prospective, randomized, open-labelled multicentre study. Diabetes Obes Metab. 2025;27(10):5432\u201343.","journal-title":"Diabetes Obes Metab"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00294-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00294-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00294-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T22:06:58Z","timestamp":1779660418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-026-00294-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1186\/s40842-026-00294-4","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Ethical Committee in Stockholm (Dnr: 2023-07022-02) and conducted according to the Declaration of Helsinki. According to Swedish law (Patient Data Act 2008:355, Chap.\u00a07), individual informed consent is not required when data is retrieved from the NPR, the National Cause of Death Register and the PDR. Informed consent is required when entering the NDR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"The abstract was presented as an Oral Presentation at the European Association for the Studies of Diabetes 61st Annual meeting in Vienna, Austria on the 18th of September 2025.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author information"}},{"value":"LG was contracted by Novo Nordisk for an invited lecture, without financial compensation. MP and TA report no conflicts of interest. RH received institutional lecture and advisory board fees from AstraZeneca, Pfizer, and MSD. TN has received honoraria on expert group participation from AstraZeneca, Merck Sharp & Dohme, Novo Nordisk, Eli Lilly and Company, Boehringer Ingelheim, Abbot and Amgen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}